Chest
Volume 132, Issue 2, August 2007, Pages 365-367
Journal home page for Chest

Editorials
Pulmonary Hypertension: From an Orphan Disease to a Public Health Problem

https://doi.org/10.1378/chest.07-0903Get rights and content

References (12)

There are more references available in the full text version of this article.

Cited by (0)

Dr. Humbert is Professor, Centre National de Référence sur l'Hypertension Artérielle Pulmonaire, Hôpital Antoine-Béclère, Université Paris-Sud, Assistance Publique - Hôpitaux de Paris. Dr. Khaltaev is Professor, World Health Organization. Dr. Bousquet is Professor, Clinique des Maladies Respiratoires, Hôpital Arnaud de Villeneuve, Université de Montpellier. Dr. Souza is Professor, Pulmonary Hypertension Unit, Pulmonary Department, University of Sao Paulo.

Drs. Humbert and Souza have relationships with drug companies including Actelion, Encysive, GlaxoSmithKline, Schering, Pfizer, and United Therapeutics. In addition to being investigators in trials involving these companies, relationships include consultancy services and membership of scientific advisory boards. Drs. Khaltaev and Bousquet have no conflicts of interest to disclose.

View full text